Prostaglandin prodrugs as ocular hypotensive agents

Details for Australian Patent Application No. 2007323857 (hide)

Owner Allergan, Inc.

Inventors Old, David W.; Im, Wha Bin; Ngo, Vinh X.

Agent Davies Collison Cave

Pub. Number AU-A-2007323857

PCT Pub. Number WO2008/064039

Priority 60/866,250 17.11.06 US

Filing date 14 November 2007

Wipo publication date 29 May 2008

International Classifications

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61P 27/06 (2006.01) Drugs for disorders of the senses

C07D 295/088 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Event Publications

11 June 2009 PCT application entered the National Phase

  PCT publication WO2008/064039 Priority application(s): WO2008/064039

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007323859-Internet-based computer for mobile and thin client users

2007323844-High pressure and high temperature vapor catheters and systems